pharma · Weight management · Short Bowel Syndrome
Zealand Pharma
Zealand Pharma A/S
Zealand Pharma A/S is a pharma organization headquartered in EU. Primary therapeutic focus areas include Weight management, Short Bowel Syndrome, Children with congenital hyperinsulinism, Critically Ill, Mechanically Ven
Sydmarken 11, Søborg (Copenhagen), 2860, DK HQ
1998 Founded
596 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Sydmarken 11, Søborg (Copenhagen), 2860, DK
- Founded
- 1998
- Employees
- 596
- Programs
- 18
- Drugs
- 20
- Patents
- 0
Pantoprazole 40mg
Phase 2 · small molecule · Oncology
Pantoprazole 40mg for Oncology is a Phase 2 program (small_molecule) at Zealand Pharma A/S with 1 ClinicalTrials.gov record(s).
Internal code CTNZ-2017-01
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Zealand Pharma A/S
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Oncology
- Status
- completed
- Trials
- 1